awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38984955-807AC4A8-397A-4A29-BD8D-1F62627771ED
Q38984955-807AC4A8-397A-4A29-BD8D-1F62627771ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38984955-807AC4A8-397A-4A29-BD8D-1F62627771ED
Young patients and those with a low eGFR benefitted more from denosumab therapy in femoral neck bone mineral density.
P2860
Q38984955-807AC4A8-397A-4A29-BD8D-1F62627771ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38984955-807AC4A8-397A-4A29-BD8D-1F62627771ED
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bcb840554894b2d398e6aa5dd81d6bede0f4703d
P2860
Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL.